252 related articles for article (PubMed ID: 20017671)
1. CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction.
Gaedigk A; Fuhr U; Johnson C; Bérard LA; Bradford D; Leeder JS
Pharmacogenomics; 2010 Jan; 11(1):43-53. PubMed ID: 20017671
[TBL] [Abstract][Full Text] [Related]
2. CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.
Gaedigk A; Bradford LD; Alander SW; Leeder JS
Drug Metab Dispos; 2006 Apr; 34(4):563-9. PubMed ID: 16415111
[TBL] [Abstract][Full Text] [Related]
3. Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction.
Black JL; Walker DL; O'Kane DJ; Harmandayan M
Drug Metab Dispos; 2012 Jan; 40(1):111-9. PubMed ID: 22004686
[TBL] [Abstract][Full Text] [Related]
4. The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements.
Gaedigk A; Coetsee C
Eur J Clin Pharmacol; 2008 May; 64(5):465-75. PubMed ID: 18202841
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
[TBL] [Abstract][Full Text] [Related]
6. Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype.
Daly AK; Fairbrother KS; Andreassen OA; London SJ; Idle JR; Steen VM
Pharmacogenetics; 1996 Aug; 6(4):319-28. PubMed ID: 8873218
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events.
Gaedigk A; Ndjountché L; Divakaran K; Dianne Bradford L; Zineh I; Oberlander TF; Brousseau DC; McCarver DG; Johnson JA; Alander SW; Wayne Riggs K; Steven Leeder J
Clin Pharmacol Ther; 2007 Feb; 81(2):242-51. PubMed ID: 17259947
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants.
Gaedigk A; Jaime LK; Bertino JS; Bérard A; Pratt VM; Bradfordand LD; Leeder JS
Front Pharmacol; 2010; 1():121. PubMed ID: 21833166
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans.
Gaedigk A; Bhathena A; Ndjountché L; Pearce RE; Abdel-Rahman SM; Alander SW; Bradford LD; Rogan PK; Leeder JS
Pharmacogenomics J; 2005; 5(3):173-82. PubMed ID: 15768052
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J
Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
[TBL] [Abstract][Full Text] [Related]
11. CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.
Leathart JB; London SJ; Steward A; Adams JD; Idle JR; Daly AK
Pharmacogenetics; 1998 Dec; 8(6):529-41. PubMed ID: 9918137
[TBL] [Abstract][Full Text] [Related]
12. Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection.
Qiao W; Martis S; Mendiratta G; Shi L; Botton MR; Yang Y; Gaedigk A; Vijzelaar R; Edelmann L; Kornreich R; Desnick RJ; Scott SA
Pharmacogenomics; 2019 Jan; 20(1):9-20. PubMed ID: 30730286
[TBL] [Abstract][Full Text] [Related]
13. An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype.
Panserat S; Mura C; Gérard N; Vincent-Viry M; Galteau MM; Jacoz-Aigrain E; Krishnamoorthy R
Br J Clin Pharmacol; 1995 Oct; 40(4):361-7. PubMed ID: 8554938
[TBL] [Abstract][Full Text] [Related]
14. A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.
Langaee T; Hamadeh I; Chapman AB; Gums JG; Johnson JA
PLoS One; 2015; 10(1):e0113808. PubMed ID: 25625348
[TBL] [Abstract][Full Text] [Related]
15. Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.
Steen VM; Andreassen OA; Daly AK; Tefre T; Børresen AL; Idle JR; Gulbrandsen AK
Pharmacogenetics; 1995 Aug; 5(4):215-23. PubMed ID: 8528268
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
Sachse C; Brockmöller J; Bauer S; Roots I
Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401
[TBL] [Abstract][Full Text] [Related]
17. Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.
Gaedigk A; Bradford LD; Marcucci KA; Leeder JS
Clin Pharmacol Ther; 2002 Jul; 72(1):76-89. PubMed ID: 12152006
[TBL] [Abstract][Full Text] [Related]
18. CYP2D6: novel genomic structures and alleles.
Kramer WE; Walker DL; O'Kane DJ; Mrazek DA; Fisher PK; Dukek BA; Bruflat JK; Black JL
Pharmacogenet Genomics; 2009 Oct; 19(10):813-22. PubMed ID: 19741566
[TBL] [Abstract][Full Text] [Related]
19. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
[TBL] [Abstract][Full Text] [Related]
20. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism.
Topić E; Stefanović M; Nikolić V; Zoricić I; Ivanisević AM; Zuntar I
Clin Chem Lab Med; 1998 Aug; 36(8):655-8. PubMed ID: 9806480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
